Please login to the form below

Not currently logged in

BioMarin’s chief commercial officer joins True North’s board

Jeff Ajer brings over 20 years of industry experience to the biotech

True North Therapeutics Jeff AjerCalifornia, US-based biotech True North Therapeutics has appointed Jeff Ajer to its board of directors as an independent director.

Ajer currently serves as executive vice president and chief commercial officer of BioMarin, and was previously the firm's vice president of commercial operations for the Americas.

He first joined BioMarin in 2005 from Genzyme, where he was vice president of global transplant operations, and prior to this held a series of sales, marketing and operations positions at SangStat Medical Corporation and ICN Pharmaceuticals.

Nancy Stagliano, chief executive officer of True North Therapeutics, said: “We are delighted that Jeff has joined our board.

“We believe his extensive commercial experience with products for rare diseases, which includes over 11 years at BioMarin where he built the company's commercial infrastructure and led successful drug launches, will be invaluable as we continue to build a pipeline of innovative medicines designed to treat Complement-mediated rare diseases.”

20th February 2017

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
FCB Halesway

A Eureka moment! A converted dairy in the Hampshire countryside back in 1993 saw the inception of Halesway as a...

Latest intelligence

figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...
The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...